Eisler Capital (Uk) Ltd. Bristol Myers Squibb CO Put Options Transaction History

Eisler Capital (Uk) Ltd.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $12.3 Million - $16 Million	309,257 Added 91.58%	646,950 $33.5 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $712,867 - $938,505	-17,711 Reduced 4.98%	337,693 $14 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $9.57 Million - $10.9 Million	199,487 Added 127.94%	355,404 $19.3 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $6.7 Million - $8 Million	138,272 Added 783.63%	155,917 $8 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1.02 Million - $1.14 Million	17,645 New	17,645 $1.02 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $43.6 Million - $48 Million	-600,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $36.9 Million - $44.2 Million	600,000 New	600,000 $43.8 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.